Business · 11/12/2000Updated: 10/17/2026 · 1 min read
FDA Announces Collection of Information for Blood Product Shipment Review
Summary
The Food and Drug Administration (FDA) is requesting public comment on its proposed collection of information related to the shipment of blood products containing the hepatitis B surface antigen (HbsAg) before completion of testing, as required by the Paperwork Reduction Act of 1995.